View abstract

This abstract is assigned to session OB Poster session > in O'Bistro

Title

Iridium Brachytherapy for conjunctival melanoma of the fornix.

Purpose	To investigate the usefullness of brachytherapy in stead of exenteration in the management of high-risk conjunctival melanoma patients. A patient was referred with a recurrent conjunctival melanoma of the upper fornix. The patient had previously two excisions of conjunctival melanoma of the temporal conjunctiva, without adjuvant therapy.
Methods	To demonstrate the use of iridium brachytherapy for a large, recurrent conjunctival melanoma at an unfavorable position. In a large series patients who underwent exenteration were compared with patients who underwent brachytherapy and local surgery. To advocate, once again, that adjuvant brachytherapy is the golden standard for the treatment of conjunctival melanoma.
Results	In the case, that will be used as illustrative example, the local tumor was excised and iridium brachytherapy was administered for 3 days. At the moment of excision, there were no locoregional or distant metastases. Nine months after excision there is no recurrence.
Conclusion	Iridium brachytherapy can pospone or even avoid exenteration in the treatment of conjunctival melanoma.

Author 1

Last name	MISSOTTEN
Initials	GS
Department	Katholieke Universiteit Leuven
City	Leuven

Author 2

Last name	Van Limbergen
Initials	E
Department	Katholieke Universiteit Leuven - Radiotherapie
City	Leuven

Author 3

Last name	Van Ginderdeuren
Initials	R
Department	Katholieke Universiteit Leuven
City	Leuven

Author 4

Last name	Vandelanotte
Initials	S
Department	Katholieke Universiteit Leuven
City	Leuven

Author 5

Last name	Spileers
Initials	W
Department	Katholieke Universiteit Leuven
City	Leuven